उत्पाद विवरण
Bosutris 400 mg Tablet is a targeted therapy designed to combat certain types of cancer, primarily chronic myeloid leukemia (CML) that is Philadelphia chromosome-positive. The active ingredient, Bosutinib, works by inhibiting specific proteins that contribute to the growth and proliferation of cancer cells, thereby slowing the progression of the disease. Patients using Bosutris should be aware of potential side effects, including gastrointestinal issues and blood-related complications, and should regularly consult with their healthcare provider to monitor their response to the treatment. This medication is generally prescribed for adults and should be taken as directed to maximize its effectiveness while minimizing risks. As with any cancer treatment, it is crucial to inform your physician about any other medications or health conditions you may have. Bosutris 400 mg Tablet is a vital option in the evolving landscape of cancer therapies, providing hope and improved outcomes for patients battling CML. Always adhere to your doctors recommendations and report any unusual symptoms promptly to ensure safe and effective treatment.